Curon Medical Invites You to Join Its First Quarter Conference Call on the Web

Apr 19, 2001, 01:00 ET from Curon Medical, Inc.

    NEW YORK, April 19 /PRNewswire Interactive News Release/ -- In conjunction
 with Curon Medical's first quarter, you are invited to listen to its
 conference call that will be broadcast live over the Internet on Thursday,
 April 26, 2001, at 4:30 p.m. EDT with John W. Morgan, President and Chief
 Executive Officer and Alistair F. McLaren, Vice President and Chief Financial
 Officer.
 
     What:      Curon Medical's First Quarter Earnings Release
 
     When:      April 26, 2001 at 4:30 p.m. EDT
 
     Where:     http://www.videonewswire.com/CURON/042601/
 
     How:       Live over the Internet -- Simply log on to the web at the
                address above
 
     Contact:   Curon Medical, Noonan/Russo Communications, 415-677-4455, x209.
 
     Curon Medical, Inc. of Sunnyvale, Calif. (Nasdaq:   CURN), develops,
 manufactures and markets innovative proprietary products for the treatment of
 gastrointestinal disorders. The company's products consist of radiofrequency
 generators and single-use disposable devices. Its first product, the
 Stretta(TM) System, received United States Food and Drug Administration
 clearance in April 2000 for the treatment of gastroesophageal reflux disease,
 commonly referred to as GERD.  For more information, please visit the
 Company's Web site at http://www.curonmedical.com.
 
     If you are unable to participate during the live webcast, the call will be
 archived on the Web site http://www.curonmedical.com.  To access the replay,
 click on http://www.investor-curonmedical.com/
     (Minimum Requirements to listen to broadcast: The RealPlayer software,
 downloadable free from http://www.real.com/products/player/index.html, and at
 least a 14.4Kbps connection to the Internet.  If you experience problems
 listening to the broadcast, send an email to webmaster@vdat.com.)
 
                     MAKE YOUR OPINION COUNT -- Click Here
                http://tbutton.prnewswire.com/prn/11690X42594543
 
 

SOURCE Curon Medical, Inc.
    NEW YORK, April 19 /PRNewswire Interactive News Release/ -- In conjunction
 with Curon Medical's first quarter, you are invited to listen to its
 conference call that will be broadcast live over the Internet on Thursday,
 April 26, 2001, at 4:30 p.m. EDT with John W. Morgan, President and Chief
 Executive Officer and Alistair F. McLaren, Vice President and Chief Financial
 Officer.
 
     What:      Curon Medical's First Quarter Earnings Release
 
     When:      April 26, 2001 at 4:30 p.m. EDT
 
     Where:     http://www.videonewswire.com/CURON/042601/
 
     How:       Live over the Internet -- Simply log on to the web at the
                address above
 
     Contact:   Curon Medical, Noonan/Russo Communications, 415-677-4455, x209.
 
     Curon Medical, Inc. of Sunnyvale, Calif. (Nasdaq:   CURN), develops,
 manufactures and markets innovative proprietary products for the treatment of
 gastrointestinal disorders. The company's products consist of radiofrequency
 generators and single-use disposable devices. Its first product, the
 Stretta(TM) System, received United States Food and Drug Administration
 clearance in April 2000 for the treatment of gastroesophageal reflux disease,
 commonly referred to as GERD.  For more information, please visit the
 Company's Web site at http://www.curonmedical.com.
 
     If you are unable to participate during the live webcast, the call will be
 archived on the Web site http://www.curonmedical.com.  To access the replay,
 click on http://www.investor-curonmedical.com/
     (Minimum Requirements to listen to broadcast: The RealPlayer software,
 downloadable free from http://www.real.com/products/player/index.html, and at
 least a 14.4Kbps connection to the Internet.  If you experience problems
 listening to the broadcast, send an email to webmaster@vdat.com.)
 
                     MAKE YOUR OPINION COUNT -- Click Here
                http://tbutton.prnewswire.com/prn/11690X42594543
 
 SOURCE  Curon Medical, Inc.